According to the latest study on “Pulse Oximeters Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Type, Sensor Type, and End User,” the market was valued at US$ 1,892.00 million in 2019 and is projected to reach US$ 3,693.92 million by 2027; it is expected to grow at a CAGR of 8.6% during 2020–2027. The report highlights trends prevailing in the global pulse oximeters market, and drivers and restraints pertaining to the market growth.
Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100001437/
The growth of the pulse oximeters market is attributed to the increasing prevalence of respiratory diseases and growing preference for remote patient monitoring. Further, the strategic developments by manufacturers offer lucrative opportunities to the global pulse oximeters market players. However, the inaccuracies in pulse oximeter readings due to several factors hinder the market growth.
On the basis of type, the pulse oximeters market is sub-segmented into fingertip pulse oximeters, handheld pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. In 2019, the fingertip pulse oximeters segment accounted for the largest share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in pulse oximeters devices.
Nonin; Koninklijke Philips N.V.; Vyaire Medical, INC; Smiths Medical; Hill Rom Holding Inc.; Edwards Lifesciences Corporation; Medtronic; Masimo; Beurer GmbH; and Maxtec are among the key players operating in the pulse oximeters market. These companies focus on partnerships, product launches, and collaborations, among other business strategies, to sustain their market positions. For instance, in July 2020, Nonin Medical has received 510(k) clearance for its flagship product — the CO-Pilot wireless handheld multi-parameter system. The product is meant for EMS, firefighters and military personnel to measure key vital signs following a cardiac arrest, traumatic injury, carbon monoxide or smoke inhalation.
Increasing Prevalence of Respiratory Diseases Drives Market Growth
The growing prevalence of the respiratory diseases is related to the decrease in the size of the upper airway lumen with increasing age of individuals. A large percentage of population suffers from various types of respiratory diseases globally. Smoking, genetic factors, and infections are among the common factors causing respiratory diseases. Chronic obstructive pulmonary disease (COPD), sleep apnea, cardiac arrhythmia, ischemic conditions, diabetes, hypertension, and asthma are among the medical conditions exerting significant burden on public healthcare system in various countries. As per the American Lung Association, COPD is the third leading cause of death in the US, wherein more than 16.4 million people are diagnosed with the condition. In addition, as per the US Department of Health and Human Services, ~25 million people in the US had asthma in 2019, which is one of the world’s most common respiratory diseases. The patients suffering from these respiratory disorders commonly experience difficulty in breathing and oxygen shortage. A pulse oximeter provides a non-invasive and safe method for the measurement of oxygen saturation.
The increasing number of COVID-19 cases worldwide is also boosting the demand for pulse oximeters. The continuous monitoring of respiratory parameters is one of the prime stages in the treatment of COVID-19 patients. Therefore, for the accurate management and treatment of COVID-19 cases, healthcare professionals are dependent on pulse oximeters and other multi-parameter monitors. Moreover, different types of pulse oximeter devices are being widely used for routine monitoring at home.
The report segments the global pulse oximeters market as follows:
By Sensor Type
By End User
Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPHE100001437/